Skip to content
Nobel Jews
Portrait of Joshua Lederberg
Photo: Unknown, http://profiles.nlm.nih.gov/BB/B/B/Q/C/ · Public domain via Wikimedia Commons

Nobel Prize in Physiology or Medicine · 1958

Joshua Lederberg

He showed that bacteria swap genes, opening the way to genetic engineering and to understanding how germs share drug resistance.

The Nobel citation: “for his discoveries concerning genetic recombination and the organization of the genetic material of bacteria”
Born
May 23, 1925, Montclair, NJ, USA
Died
February 2, 2008, New York, NY, USA
Shared with
George Beadle, Edward Tatum
Affiliation at the time
University of Wisconsin, USA

Medicine prize

1958

Shared with 2 other laureates.

Age that year

33years

Born in 1925.

Headline credited impact

$15–20billion in economic value

Cumulative global sales of genetically engineered non-antibody protein medicines (a proxy for economic activity). How it was built

Sources cited

27

Fact-checked September 24, 2026.

  • He won a Nobel Prize at 33. The key experiment, showing that bacteria swap genes, took him about six weeks in 1946, on leave from medical school to work at Yale.
  • He coined the word plasmid in 1952. Plasmids later became the carriers used to put genes for human proteins, such as insulin, into bacteria.
  • He gave his Nobel gold medal to the University of Wisconsin, to thank it for supporting the research the prize honored.
  • Worried that spacecraft could carry germs between worlds, he pushed for sterilizing probes, and helped design instruments to look for life on Mars.
  • He advised nine US presidential administrations and co-chaired the 1992 report that put emerging infections on the public-health agenda.

The breakthrough

Bacteria can mate and share genes: conjugation, transduction and plasmids (1946-1952)

Before 1946, most scientists thought bacteria were too simple to have genes worth studying. Bacteria seemed to multiply only by splitting in two, so every descendant should be an identical copy. Lederberg doubted it. Working with Edward Tatum at Yale, he took two mutant strains of the gut bacterium E. coli, each unable to make certain nutrients. Kept apart, neither strain could grow on plain food jelly. Mixed together, they produced a few cells that could make everything they needed and passed that ability to their offspring. The strains had swapped genes, a kind of bacterial mating now called conjugation. At the University of Wisconsin he and his student Norton Zinder found another route: viruses that infect bacteria can pick up a scrap of one cell's DNA and carry it into another. He named this transduction. Picture a courier who accidentally slips a page from one library's book into his bag and delivers it to another library, where it gets bound into a new book. In 1952 he also coined the word plasmid for genes that live outside the main chromosome, and with his wife, Esther Lederberg, he developed replica plating, which used velvet to stamp copies of bacterial colonies onto fresh dishes. Together these findings made bacteria the fastest, simplest tool for studying how genes work.[1],[4],[6],[7],[13],[14],[15]

“We weren't looking for transduction--we bumped into it. We weren't looking for plasmids--we bumped into them.”
Joshua Lederberg, Recalling the discoveries of his small Wisconsin laboratory in the late 1940s and early 1950s, as quoted by the US National Library of Medicine's Profiles in Science.[7]

What it meant for humanity

Lederberg's experiments opened bacteria to genetics, and that changed biology, medicine and industry. Bacteria grow fast and can be screened by the billions, so E. coli became a central tool for learning how genes work. His discoveries also became working tools. Plasmids, the name he gave in 1952 to genes that live outside the chromosome, were the carriers used in the first gene-cloning experiments in 1973. Loaded with genes for human insulin, plasmids turned bacteria into insulin factories, and in 1982 Humulin became the first insulin made with recombinant DNA. Transduction, in which a virus ferries genes between cells, pointed toward the virus-based gene carriers later used in gene therapy. His work also explained a medical puzzle. Conjugation and transduction let bacteria pick up drug-resistance genes from other strains faster than mutation alone would allow, while replica plating showed that resistant mutants arise on their own rather than being created by the drug. Later in life he turned to protecting the public. He advised US officials during the negotiations that produced the 1972 Biological Weapons Convention. In 1992 he co-chaired an Institute of Medicine report that defined emerging and re-emerging infections; it led the Centers for Disease Control and Prevention (CDC) to build new surveillance programs and gave rise to a scientific journal devoted to the problem. With Edward Feigenbaum and Carl Djerassi he built DENDRAL, the first expert system for science. He also warned that spacecraft could spread microbes between worlds, a concern behind quarantine rules for space travel. He advised government on health, space and security across nine presidential administrations.

  • Plasmids, a word Lederberg introduced in 1952, became the carriers of genetic engineering: in 1973 Stanley Cohen, Herbert Boyer and colleagues joined pieces of different plasmids in a test tube and showed they worked inside E. coli.[7],[15],[16]
  • Plasmids carrying genes for human insulin turned bacteria into insulin makers. Humulin, the first insulin made with recombinant DNA, went on sale in 1982.[7],[26]
  • His gene-transfer discoveries explained how bacteria can gain drug-resistance genes from other strains, far faster than mutation alone allows, reshaping how scientists see infectious disease.[7],[11],[12]
  • The 1992 Emerging Infections report he co-chaired reshaped CDC's work. With his advice the agency drew up new national strategies and built programs such as FoodNet, and its journal Emerging Infectious Diseases grew out of the report.[12],[27]
  • DENDRAL, begun in 1965 with Edward Feigenbaum and Carl Djerassi, worked out the structure of unknown chemical compounds from instrument data. It was the first expert system for scientific research.[9],[10]

Impact in numbers

Lederberg's largest contributions cannot be counted cleanly. He showed that bacteria have genes that can be mixed and moved, which made E. coli a workhorse of molecular biology, and his discoveries of conjugation and transduction, along with the plasmid idea, help explain how drug resistance spreads between germs. We record one conservative ripple claim under the shared recombinant-DNA outcome, using the same total as the Paul Berg and Arthur Kornberg profiles, and credit him with 1 percent. Plasmid and virus carriers for genes drew on the gene-transfer systems his laboratory studied, but the cloning methods, phage lambda (Esther Lederberg's discovery), the F factor (which she co-discovered), and the long work of turning genes into medicines belonged to others. We make no numeric claim for his public-health work. The 1992 Emerging Infections report reshaped US disease surveillance, and he helped build the case for the Biological Weapons Convention, but no study counts the lives either saved. DENDRAL and his warnings about spreading microbes between planets shaped artificial intelligence and space exploration in ways that also resist pricing.

HealthFundamental scienceTechnologyEconomySpacePeace

Each number is the laureate’s credited share of a real-world outcome, cumulative to 2025. The whole outcome, the share of credit, and the reasoning are shown so you can check the arithmetic. Outcomes shared with other laureates are counted once on the impact page.

  • Low confidenceRippleModeledEconomy

    Cumulative global sales of genetically engineered non-antibody protein medicines (a proxy for economic activity)

    $15–20

    billion in economic value, credited share

    That is 1% of $1.5–2 trillion in economic value since 1982.

    How this number was built

    Same outcome and range as the Berg and Kornberg profiles: world sales of recombinant non-antibody protein medicines since Humulin (1982), excluding antibodies and mRNA vaccines. Inputs: 2013 antibody sales ~$75B were about half of biopharma, so non-antibody ~$75B (Ecker 2015); 2021 non-antibody originators $53.6B, biosimilars $11.1B (Walsh 2022). Low: quadratic ramp 1982-2013 ($0.81T) + linear fall to $53.6B in 2014-21 ($0.50T) + flat 2022-25 ($0.21T) = ~$1.5T. High: linear ramp ($1.2T) + same later years + an assumed half of biosimilar sales (~$0.07T) = ~$2.0T. Nominal dollars; sales measure spending, not benefit. Share 0.01 (~$15-20B): cloning vectors drew on his gene-transfer work and plasmid concept, but Esther Lederberg (lambda, co-discoverer of F), R-factor researchers, Cohen and Boyer, Berg (0.05), Kornberg (0.02), restriction-enzyme finders and industry did the rest.[7],[15],[16],[24],[25],[26]

    Sources: Nature Biotechnology (via PubMed Central); mAbs (via PubMed Central); J Community Hosp Intern Med Perspect (via PubMed Central); Proceedings of the National Academy of Sciences (via PubMed Central); Plasmid (via PubMed); US National Library of Medicine

The double edge

His record has shadows in both science and public service. The first concerns credit. His first wife, Esther Lederberg, discovered the virus lambda, helped develop replica plating and co-discovered the F fertility factor, yet she never received tenure, and his Nobel lecture thanked her only briefly, though it did cite her lambda experiments. The second concerns judgment in two policy episodes. After a 1986 trip to Moscow he found Soviet doctors' account of a 1979 anthrax outbreak in Sverdlovsk convincing; they blamed tainted meat, but a 1994 study traced it to spores that escaped from a military facility. In 1994 he chaired a Pentagon task force that reported no evidence US troops had been exposed to chemical or biological weapons in Kuwait or Saudi Arabia. Veterans' advocates attacked the finding, critics said he should have disclosed his seat on the board of a nonprofit that had earlier shipped pathogens to Iraq, and a 2002 Defense Department report found that some troops were likely exposed to very low levels of nerve agent when US forces blew up an Iraqi weapons depot. Finally, the gene-transfer knowledge he helped create could make germs deadlier, a danger he warned about for decades.

  • Moderate

    An overlooked scientific partner

    Esther Lederberg discovered phage lambda, helped develop replica plating and co-discovered the F fertility factor, which helped explain how bacterial mating works. A 2025 tribute in the journal Genetics says her work was often attributed to her husband and that she never received tenure. His Nobel lecture thanked many colleagues, above all his wife, and mentioned her lambda crosses, but gave her work little space.[3],[14],[17]

  • Minor

    Misreading the Sverdlovsk anthrax outbreak

    After meeting Soviet doctors in Moscow in 1986, Lederberg wrote that he had very little doubt they were describing an epidemic of intestinal anthrax from tainted meat, and argued the US should stop citing the outbreak as evidence of a treaty violation. In 1994 Matthew Meselson's team showed the outbreak was caused by airborne anthrax that leaked from a military microbiology facility.[20],[21]

  • Moderate

    The Gulf War illness task force

    His 1994 Defense Science Board task force reported no evidence of chemical or biological weapons exposure in Kuwait or Saudi Arabia. Critics said he should have disclosed his unpaid board seat at a nonprofit that made 70 approved pathogen shipments to Iraq in 1985-1989, before he joined. A 2002 Pentagon report found some troops were likely exposed to very low levels of nerve agent when US forces blew up Iraqi rockets at Khamisiyah, Iraq, in March 1991.[8],[18],[19]

  • Minor

    Knowledge that could make germs deadlier

    The same gene-transfer science that powers biotechnology could be used to engineer bacteria and viruses that are more virulent or resistant to drugs. Lederberg saw this risk clearly: he called biological weapons uncontrollable and indiscriminate and spent decades working for arms control.[8],[10]

Against the odds

Lederberg did not face violence or legal persecution. He grew up in New York in the 1930s, when antisemitism in the United States was common and often built into institutions. His parents, an Orthodox rabbi and his wife, had arrived from Palestine the year before he was born, and the family settled in Washington Heights in upper Manhattan. Columbia, where he enrolled in 1941, had been among the first elite universities to limit Jewish admissions about two decades earlier, using tools such as personal interviews and recruiting from distant states to hold down the number of Jewish New Yorkers. Most American medical schools had capped Jewish enrollment since the 1920s, and those quotas were still entrenched in 1945. Lederberg got through anyway. A $400 scholarship took him to Columbia College at 16, and the Navy's wartime V-12 program carried him into its medical school. No source we found says he was personally turned away because he was Jewish. His memoir records a quieter cost: as the son of an Orthodox rabbi, he was uneasy about leaving New York for Wisconsin in 1947, far from the community and mentors he knew, and he started that job in debt after paying back tuition to receive his Yale doctorate.

  • 1941

    Quota

    He entered Columbia College in 1941, about two decades after Columbia began limiting Jewish admissions with tools such as interviews and recruiting from distant states. He was admitted with a $400 scholarship; no source says he was personally rejected anywhere.[5],[23]

  • 1944

    Quota

    He began medical school at Columbia's College of Physicians and Surgeons in 1944 through a Navy training program, at a time when quotas limiting Jewish students were entrenched at most US medical schools.[5],[10],[22]

  • 1947

    Other

    Raised in New York as the son of an Orthodox rabbi, he was uneasy about moving to the Midwest, far from the community and mentors he had relied on. He took the Wisconsin job newly married and in debt from back tuition owed to Yale.[10]

Jewish background

Both parents JewishIdentified as Jewish, secular

Lederberg was born to Jewish parents who had come to the United States from Palestine the year before. His father, Zvi H. Lederberg, was an Orthodox rabbi, and his mother, Esther Goldenbaum Schulman, descended from generations of rabbinical scholars. His father hoped he would follow a religious calling; they later agreed that science, like religious study, was a worthy way to seek truth. His most prized bar mitzvah gift was a biochemistry textbook. His National Academy of Sciences memoir says he did not practice Judaism as an adult but felt a deep connection to it, and was delighted to receive honorary degrees from Yeshiva University, the Jewish Theological Seminary and Tel Aviv University.[2],[5],[10]

Key dates

  1. May 23, 1925

    Born in Montclair, New Jersey, the eldest of three sons of an Orthodox rabbi and his wife, who had come from Palestine the year before.[1],[5],[10]

  2. 1941

    After graduating from Stuyvesant High School at 15, enters Columbia College as a zoology student with a $400 scholarship.[5],[10]

  3. 1944

    Earns his BA from Columbia and, through the Navy's V-12 program, starts medical school at Columbia's College of Physicians and Surgeons.[2],[5],[10]

  4. 1946

    At Yale with Edward Tatum, shows in about six weeks that E. coli bacteria can mate and exchange genes. Marries microbiologist Esther Zimmer.[2],[6],[10]

  5. 1947

    Becomes assistant professor of genetics at the University of Wisconsin instead of returning to medical school; Yale awards his PhD (the Nobel biography says 1948).[2],[5],[10]

  6. 1952

    Publishes the discovery of transduction with Norton Zinder and of replica plating with Esther Lederberg, and coins the word plasmid.[13],[14],[15]

  7. 1957

    Founds and chairs Wisconsin's Department of Medical Genetics and is elected to the National Academy of Sciences.[2],[10]

  8. 1958

    Wins half of the Nobel Prize in Physiology or Medicine at 33; George Beadle and Edward Tatum share the other half. Accepts Stanford's offer to found its genetics department, moving there in 1959.[1],[2],[5],[11]

  9. 1965

    Begins DENDRAL with Edward Feigenbaum and Carl Djerassi, the first expert system for scientific research.[9],[10]

  10. April 1972

    The Biological Weapons Convention is signed after Geneva negotiations on which he advised the US Arms Control and Disarmament Agency.[8],[10]

  11. 1978

    Becomes president of Rockefeller University in New York, serving until 1990.[2],[10]

  12. 1992

    Co-chairs the Institute of Medicine report Emerging Infections, which shaped how US agencies track new and returning diseases.[12],[27]

  13. 2006

    Receives the Presidential Medal of Freedom.[10]

  14. February 2, 2008

    Dies of pneumonia in New York, aged 82.[1],[10],[11]

Sources

  1. 1.Joshua Lederberg - Facts · NobelPrize.org (Nobel Prize Outreach)
  2. 2.Joshua Lederberg - Biographical (1958, with addenda from 1997 and 2005) · NobelPrize.org (from Les Prix Nobel / Nobel Lectures, Physiology or Medicine 1942-1962), 1958
  3. 3.A View of Genetics (Nobel Lecture, 29 May 1959) · NobelPrize.org, 1959
  4. 4.Award ceremony speech, Nobel Prize in Physiology or Medicine 1958 (Professor T. Caspersson) · NobelPrize.org, 1958
  5. 5.Biographical Overview - Joshua Lederberg, Profiles in Science · US National Library of Medicine
  6. 6.The Development of Bacterial Genetics - Joshua Lederberg, Profiles in Science · US National Library of Medicine
  7. 7.Transduction, Plasmids, and the Foundation of Biotechnology - Joshua Lederberg, Profiles in Science · US National Library of Medicine
  8. 8.Science and the Public Interest - Joshua Lederberg, Profiles in Science · US National Library of Medicine
  9. 9.Computers, Artificial Intelligence, and Expert Systems in Biomedical Research - Joshua Lederberg, Profiles in Science · US National Library of Medicine
  10. 10.Joshua Lederberg, 1925-2008: A Biographical Memoir (S. Gaylen Bradley) · National Academy of Sciences, 2009
  11. 11.Geneticist, Nobel laureate Joshua Lederberg dies at 82 · Stanford Medicine News Center, 2008
  12. 12.In Memoriam: Joshua Lederberg (1925-2008) (Hughes JM, Drotman DP), Emerging Infectious Diseases 14(6) · Centers for Disease Control and Prevention, 2008
  13. 13.Genetic exchange in Salmonella (Zinder ND, Lederberg J), Journal of Bacteriology 64(5):679-699 · Journal of Bacteriology (via PubMed Central), 1952
  14. 14.Replica plating and indirect selection of bacterial mutants (Lederberg J, Lederberg EM), Journal of Bacteriology 63(3):399-406 · Journal of Bacteriology (via PubMed Central), 1952
  15. 15.Plasmid (1952-1997) (Lederberg J), Plasmid 39(1):1-9 · Plasmid (via PubMed), 1998
  16. 16.Construction of biologically functional bacterial plasmids in vitro (Cohen SN, Chang ACY, Boyer HW, Helling RB), PNAS 70(11):3240-3244 · Proceedings of the National Academy of Sciences (via PubMed Central), 1973
  17. 17.Pioneer of bacterial genetics: the legacy of Esther Miriam Lederberg (Wendling CC, Bailey ZM), Genetics 231(3) · Genetics (via PubMed Central), 2025
  18. 18.Head of Gulf War Illness Panel Had Ties to Chemical Supplier · The Seattle Times, 1996
  19. 19.Chemical & Biological Weapons during Gulf War · US Department of Veterans Affairs, Public Health
  20. 20.Observations from Lederberg during his presence at the joint U.S.-U.S.S.R. CISAC meeting in Moscow in October 1986 (memo dated 12 October 1986) · US National Library of Medicine, Joshua Lederberg Papers, 1986
  21. 21.The Sverdlovsk anthrax outbreak of 1979 (Meselson M, Guillemin J, Hugh-Jones M, et al.), Science 266(5188):1202-1208 · Science (via PubMed), 1994
  22. 22.Why Did the United States Medical School Admissions Quota for Jews End? (Halperin EC), Am J Med Sci 358(5):317-325 · American Journal of the Medical Sciences (via PubMed), 2019
  23. 23.How the Ivy League's Jewish quotas shaped higher education (Susan H. Greenberg) · Inside Higher Ed, 2022
  24. 24.Biopharmaceutical benchmarks 2022 (Walsh G, Walsh E), Nature Biotechnology 40:1722-1760 · Nature Biotechnology (via PubMed Central), 2022
  25. 25.The therapeutic monoclonal antibody market (Ecker DM, Jones SD, Levine HL), mAbs 7(1):9-14 · mAbs (via PubMed Central), 2015
  26. 26.History of insulin (Quianzon CC, Cheikh I), Journal of Community Hospital Internal Medicine Perspectives 2(2) · J Community Hosp Intern Med Perspect (via PubMed Central), 2012
  27. 27.Emerging Infections: Microbial Threats to Health in the United States (Institute of Medicine, 1992) · The National Academies Press, 1992

Fact-checked on September 24, 2026 by a separate AI fact-checking pass that re-opened the sources, with 14 corrections made. How we check

Suggest a correction